Clinical Trial Update: T-cell Depleted Alternative Donor Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of T-cell depleted alternative donor transplantation for acute leukemias and related conditions was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2017-11-08